Aspen Neuroscience Pursues Autologous Cell Therapies for Parkinson’s with $147.5M Series B
The Scripps Research spinout eyes 2023 for dosing of its first patients with its first product, designed to treat idiopathic Parkinson’s disease.
Aspen Neuroscience collects large Series B to compete against Bayer’s Parkinson’s cell therapy
Damien McDevitt thinks frequently about the name Aspen Neuroscience. Specifically, should the neuroscience portion be dropped as the San Diego biotech considers expanding beyond the CNS?
An Autologous Stem Cell-Based Therapy for Parkinson’s Disease
Cell therapies hold great promise to treat Parkinson’s disease, but there’s an ongoing debate over how to best do this. One group—and I am firmly in this camp—maintains an autologous therapy, derived from a patient’s own cells, is the correct…
Aspen Neuroscience Gets $70 Million Series A Funding Round
Aspen Neuroscience, a private biotech company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, announced the close of its Series A funding round of $70 million. OrbiMed led the investment round with participation from ARCH Venture Partners,…
$70 Million Raised for Neuron Replacement Therapy Techniques to Treat Parkinson’s
Aspen Neuroscience has raised $70 million to advance the development of Parkinson’s disease therapies using patients’ own cells. The products, ANPD001 and ANPD002, are the first-ever Parkinson’s treatments designed to use a patient’s own cells as a replacement to restore…
Possible Parkinson’s Stem Cell Treatment in San Diego, $6.5 Million and Loads of Media Coverage
A San Diego firm that has $22 million worth of financial roots in the California stem cell agency this month snagged a bonus — a ton of favorable attention for its efforts to treat Parkinson’s disease. The fledgling business is…
Pioneering cell therapy for Parkinson’s disease gains funding boost
An autologous stem cell therapy for Parkinson’s disease (PD), with a potential to alter disease progression, received a boost when the programme received a seed funding totalling $6.5m from a group of venture capitalist firms. The funding is likely to…
How Research in Space Can Launch Girls’ Ideas
What if… …examining barley seeds in microgravity could help us grow food in space and improve crop growth back on the ground? …sending mice into orbit could teach us how to prevent human bone and muscle loss on Earth? …researching…
Jeanne Loring named ‘Stem Cell Pioneer of the Year’ in inaugural Xconomy Awards
Genomics researcher Jeanne Loring, PhD, professor emeritus at Scripps Research and founding director of the institute’s Center for Regenerative Medicine, was honored as “Stem Cell Pioneer of the Year” at the Xconomy Awards San Diego’s gala. The award is an…
The first 3D models of Parkinson’s, MS are headed into space
A group of brain organoids are set to blast off to the International Space Station (ISS) Wednesday, the first to model Parkinson’s disease and multiple sclerosis (MS) in microgravity. A team of researchers from across the country believes the models…